CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.280
+0.350 (18.13%)
Oct 14, 2025, 3:33 PM EDT - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $26.31 million as of October 14, 2025. Its market cap has increased by 55.10% in one year.
Market Cap
26.31M
Enterprise Value
20.41M
1-Year Change
55.10%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $26.31M, a decrease of -42.95%. That is a compound annual growth rate of -20.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 22.27M | -43.24% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |